Bispecific T Cell Engager Therapeutics Market Applications in...

أضاف وظيفة جديدة Health

2026-07-07 06:31:00 -

Bispecific T Cell Engager Therapeutics Market Applications in Hematological Oncology

The hematological oncology sector represents the primary application area for bispecific T cell engager therapeutics, leveraging the platform's ability to achieve deep responses in relapsed and refractory blood cancers. In multiple myeloma, BCMA-directed BiTE therapeutics have demonstrated remarkable efficacy in heavily pretreated patients, including those with prior exposure to CAR-T therapy,...

0 التعليقات 0 المشاركات 23 مشاهدة 0 معاينة